Gene Expression Profiling of Structural and Functional High-Risk Multiple Myeloma

被引:0
|
作者
Binder, Moritz [1 ]
Rajkumar, S. Vincent [1 ]
Lacy, Martha Q. [1 ]
Haug, Jessica L. [1 ]
Dispenzieri, Angela [1 ]
Henderson, Kimberly J. [1 ]
Kimlinger, Teresa K. [1 ]
Stewart, A. Keith [2 ]
Bergsagel, P. Leif [2 ]
Kumar, Shaji K. [1 ]
机构
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Scottsdale, AZ USA
关键词
D O I
10.1182/blood-2019-124637
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3061
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Current Review on High-Risk Multiple Myeloma
    Henry S. H. Chan
    Christine I. Chen
    Donna E. Reece
    Current Hematologic Malignancy Reports, 2017, 12 : 96 - 108
  • [42] A High-Risk Survival Classifier for Multiple Myeloma
    Kuiper, Rowan
    Broyl, Annemiek
    de Knegt, Yvonne
    van Vliet, Martin H.
    van Beers, Erik H.
    van der Holt, Bronno
    el Jarari, Laila
    Mulligan, George
    Morgan, Gareth
    Gregory, Walter M.
    Goldschmidt, Hartmut
    Lokhorst, Henk M.
    van Duin, Mark
    Sonneveld, Pieter
    BLOOD, 2011, 118 (21) : 786 - 786
  • [43] A HIGH-RISK SURVIVAL SIGNATURE FOR MULTIPLE MYELOMA
    Kuiper, R.
    Broyl, A.
    de Knegt, Y.
    van Vliet, M.
    van Beers, E.
    van der Holt, B.
    el Jarari, L.
    Mulligan, G.
    Gregory, W.
    Morgan, G.
    Goldschmidt, H.
    Lokhorst, H.
    van Duin, M.
    Sonneveld, P.
    HAEMATOLOGICA, 2012, 97 : 223 - 223
  • [44] High-risk Multiple Myeloma: Definition and Management
    Joseph, Nisha S.
    Gentili, Silvia
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S80 - S87
  • [45] Defining and treating high-risk multiple myeloma
    S Z Usmani
    P Rodriguez-Otero
    M Bhutani
    M-V Mateos
    J S Miguel
    Leukemia, 2015, 29 : 2119 - 2125
  • [46] Identification of high-risk patients in multiple myeloma using a clonal gene signature
    Li, Jian-Rong
    Wang, Christiana
    Cheng, Chao
    CANCER RESEARCH, 2024, 84 (06)
  • [47] Gene Expression Profiling (GEP) Is More Prognostic of OS and Post-ASCT PFS Compared to FISH in High-Risk Multiple Myeloma - a Single Center Experience
    Velez, Miguel Gonzalez
    Duma, Narjust
    Thakkar, Badal
    Suero, Ning Dong Giselle
    Siegel, David
    Richter, Joshua R.
    Vesole, David H.
    Biran, Noa
    BLOOD, 2017, 130
  • [48] Erratum: Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma
    Y Jethava
    A Mitchell
    M Zangari
    S Waheed
    C Schinke
    S Thanendrarajan
    J Sawyer
    D Alapat
    E Tian
    C Stein
    R Khan
    C J Heuck
    N Petty
    D Avery
    D Steward
    R Smith
    C Bailey
    J Epstein
    S Yaccoby
    A Hoering
    J Crowley
    G Morgan
    B Barlogie
    F van Rhee
    Blood Cancer Journal, 2016, 6 : e471 - e471
  • [49] Gene expression profiling for molecular identification of high-risk breast cancer patients
    Ahr, A
    Holtrich, U
    Solbach, C
    Scharl, A
    Strebhardt, K
    Karn, T
    Kaufmann, M
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2001, 61 (12) : 954 - 963
  • [50] Erratum: Prediction of high-risk Ewing's sarcoma by gene expression profiling
    Anat Ohali
    Smadar Avigad
    Rina Zaizov
    Ron Ophir
    Shirley Horn-Saban
    Ian J Cohen
    Isaac Meller
    Yehuda Kollender
    Josephine Issakov
    Isaac Yaniv
    Oncogene, 2005, 24 : 4319 - 4319